PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 11
Pages: 1  2  
Previous
 

A Neural Photo Opportunity

October 1, 2007
Dr Medina is a developmental molecular biologist and private consultant, with research interests in the genetics of psychiatric disorders.

For persons interested in selective activation, these proteins are research heaven. You could insert ChR-2 into a neuron and turn it on at will with a wavelength of light. You could drop NpHR into another neuron and turn it off at will with a wavelength of light. You could even drop both genes into a single neuron—or a group of neurons—and then turn them on and off by selectively exposing them to blue or yellow light. Not only do you have an on/off switch, you have a remote control!

Does it work in real life?

These manipulations worked as expected with cultured neural cells. The manipulations did not alter the cells' electrical properties or other normal functions—they just turned them on or off. In NpHR, the degree of inhibition could be manipulated like a dimmer switch; it was shown to be dependent on the intensity and duration of exposure to yellow light. The effect was so robust that short pulses of light could knock out single action potentials.

However good the work was in dishes, the results said little about real world biology. What about whole tissues? Whole organisms? A number of experiments investigated neural activity within increasingly sophisticated neurological backgrounds.

The first experiments involved transfecting neural tissues with specially engineered lentiviruses that carry these ion channel genes. The viruses are exposed to neural tissue, where they set up a productive infection cycle. This includes the insertion of the gene into the resident chromosomes and expression of their proteins. One such experiment infected the brains of mouse pups and the hippocampi of adult mice with viruses loaded with both ion channel genes. Subsequent assessment of the acute activity of cortical and hippocampal slices showed that neurological activity could be manipulated by simply flashing blue light (excitatory) or yellow light (inhibitory). The tissues turned on or off, depending on the wavelength deployed. This was the first evidence that complex neurological tissues could be regulated remotely with great precision and in a bidirectional manner.

The next experiments involved examining intact animals. The organism used was Caenorhabditis elegans, a tiny roundworm that is the subject of a great deal of genetic research (it has been particularly useful in elucidating the so-called genes of aging). It is possible to insert genes into specific tissues of this organism and assess changes in behavior. Such work was done on the roundworm using these ion channel genes. The creatures were specifically engineered to express the proteins in the body wall muscle cells that mediate the wiggling, swimming movement of the worm, or in the cholinergic neurons that control these muscles. The results were stunning. By flashing blue or yellow light onto the creature, they could control the wriggling, swimming behavior of the worm!

Conclusions

This is quite a technical achievement with plenty of research and clinical applications. One of the greatest potential uses of this technology is the elucidation of neuronal pathways involved in typical behaviors. Plans are under way to trace circuits involved in tactile sensations. Using animal models of human disease, other researchers are working to identify circuits relevant to depression, Parkinson disease, and epilepsy.

There are many potentially powerful applications of this technology for humans. It is possible that these switches could be used to coax neurons in the retinas of blind patients with no functioning rods or cones to fire in the presence of blue or yellow light, perhaps restoring aspects of vision.

There may even be a psychiatric application. The suitability of deep brain stimulation for patients with severe depression has been studied by researchers such as Helen S. Mayberg and colleagues for years.1 In this experimental protocol, electrodes are inserted deep in the brain in an attempt to stimulate certain neural circuits. Working something like localized electroconvulsive therapy, the hope is that activation of these circuits could successfully treat these patients. It is very possible that such photosensitive proteins might some day replace electrodes currently in use for deep brain stimulation investigations. This might allow the clinician to target only those neurons relevant to the disease. There is a large barrier to overcome before any of this could be done in humans, of course, including issues such as the insertion of these proteins into a living brain.

Still, what biologists have in hand is no less than the wish list for the alien brain mentioned at the beginning of this column. For the first time, there is the ability to turn neural circuits on and off at will and to do so from a remote location. It is an extraordinary collaboration between the behavioral, physiological, and molecular sciences. No doubt your boss at the electronics laboratory would be proud.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





Reference
1. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651-660.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • The Moral Struggles of Practicing Psychiatrists
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Experts Discuss Changes, Updates in DSM-5
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Experts Discuss Changes, Updates in DSM-5
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • The Psychiatrist and the Slot Machine
  • The Role of Biological Tests in Psychiatric Diagnosis
  • You Are—And Your Mood Is—What You Eat
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • Experts Discuss Changes, Updates in DSM-5
  • The Role of Biological Tests in Psychiatric Diagnosis
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Refinements in ECT Techniques
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy